Celcuity Management
Management criteria checks 4/4
We currently do not have sufficient information about the CEO.
Key information
Brian Sullivan
Chief executive officer
US$1.7m
Total compensation
CEO salary percentage | 12.1% |
CEO tenure | 13yrs |
CEO ownership | 8.1% |
Management average tenure | 3.4yrs |
Board average tenure | 9.5yrs |
Recent management updates
Recent updates
Celcuity: Breast Cancer Drug Developer With Upcoming Catalysts
Nov 06Is Celcuity (NASDAQ:CELC) Using Too Much Debt?
Aug 31Celcuity: Flying A Phase 3 Trial Right Under Your Nose
Jul 05Does Celcuity (NASDAQ:CELC) Have A Healthy Balance Sheet?
May 08Is Celcuity (NASDAQ:CELC) Using Too Much Debt?
Jul 04Is Celcuity (NASDAQ:CELC) A Risky Investment?
Sep 13Celcuity rises after hours on FDA Breakthrough Therapy nod for its breast cancer treatment
Jul 18Is Celcuity (NASDAQ:CELC) A Risky Investment?
Jan 27Health Check: How Prudently Does Celcuity (NASDAQ:CELC) Use Debt?
Sep 21Celcuity: Nipping The Oncogenic Bud
Jul 08What You Need To Know About Celcuity Inc.'s (NASDAQ:CELC) Investor Composition
Mar 14We're Hopeful That Celcuity (NASDAQ:CELC) Will Use Its Cash Wisely
Jan 20Celcuity inks clinical trial pact with Massachusetts General Hospital and Puma Technologies
Dec 23Could The Celcuity Inc. (NASDAQ:CELC) Ownership Structure Tell Us Something Useful?
Nov 29Celcuity EPS beats by $0.03
Nov 09CEO Compensation Analysis
Date | Total Compensation | Salary | Company Earnings |
---|---|---|---|
Sep 30 2024 | n/a | n/a | -US$94m |
Jun 30 2024 | n/a | n/a | -US$83m |
Mar 31 2024 | n/a | n/a | -US$73m |
Dec 31 2023 | US$2m | US$210k | -US$64m |
Sep 30 2023 | n/a | n/a | -US$57m |
Jun 30 2023 | n/a | n/a | -US$49m |
Mar 31 2023 | n/a | n/a | -US$45m |
Dec 31 2022 | US$2m | US$106k | -US$41m |
Sep 30 2022 | n/a | n/a | -US$36m |
Jun 30 2022 | n/a | n/a | -US$31m |
Mar 31 2022 | n/a | n/a | -US$35m |
Dec 31 2021 | US$1m | US$260k | -US$30m |
Sep 30 2021 | n/a | n/a | -US$25m |
Jun 30 2021 | n/a | n/a | -US$22m |
Mar 31 2021 | n/a | n/a | -US$10m |
Dec 31 2020 | US$469k | US$250k | -US$9m |
Sep 30 2020 | n/a | n/a | -US$9m |
Jun 30 2020 | n/a | n/a | -US$8m |
Mar 31 2020 | n/a | n/a | -US$8m |
Dec 31 2019 | US$992k | US$250k | -US$7m |
Sep 30 2019 | n/a | n/a | -US$7m |
Jun 30 2019 | n/a | n/a | -US$7m |
Mar 31 2019 | n/a | n/a | -US$7m |
Dec 31 2018 | US$564k | US$250k | -US$7m |
Compensation vs Market: Brian's total compensation ($USD1.74M) is about average for companies of similar size in the US market ($USD2.23M).
Compensation vs Earnings: Brian's compensation has been consistent with company performance over the past year.
CEO
Brian Sullivan (62 yo)
13yrs
Tenure
US$1,738,115
Compensation
Mr. Brian F. Sullivan is the Co-Founder of Celcuity Inc. and has been its Chairman and Chief Executive Officer since 2012 and served as its Chief Financial Officer. Mr. Sullivan Co-founded Entegris, Inc. i...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 13yrs | US$1.74m | 8.12% $ 41.1m | |
Co-Founder | 13yrs | US$1.48m | 3.37% $ 17.0m | |
Chief Financial Officer | 7.5yrs | US$898.74k | 0.050% $ 252.8k | |
General Counsel | less than a year | no data | no data | |
Acting Head of Clinical Operations | 4yrs | no data | no data | |
Chief Medical Officer | 2.8yrs | no data | no data | |
Chief Commercial Officer | less than a year | no data | no data | |
Senior Vice President of Clinical Development | less than a year | no data | no data |
3.4yrs
Average Tenure
62yo
Average Age
Experienced Management: CELC's management team is considered experienced (3.4 years average tenure).
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Co-Founder | 13yrs | US$1.74m | 8.12% $ 41.1m | |
Co-Founder | 13yrs | US$1.48m | 3.37% $ 17.0m | |
Independent Director | 8yrs | US$87.50k | 0.27% $ 1.4m | |
Independent Director | 10.9yrs | US$87.50k | 0.025% $ 127.0k | |
Independent Director | 5.7yrs | US$87.50k | 0.029% $ 146.4k | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | no data | no data | no data | |
Member of Scientific Advisory Board | 6yrs | no data | no data |
9.5yrs
Average Tenure
66yo
Average Age
Experienced Board: CELC's board of directors are considered experienced (9.5 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/05 05:26 |
End of Day Share Price | 2025/01/03 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Celcuity Inc. is covered by 11 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Arlinda Lee | Canaccord Genuity |
Chase Knickerbocker | Craig-Hallum Capital Group LLC |
Alexander Nowak | Craig-Hallum Capital Group LLC |